Yue C, Zhou H, Wang X, Yu J, Hu Y, Zhou P
MedComm (2020). 2024; 5(12):e70029.
PMID: 39654684
PMC: 11625510.
DOI: 10.1002/mco2.70029.
Jappe U, Bergmann K, Brinkmann F, Faihs V, Gulsen A, Klimek L
Allergol Select. 2024; 8:365-406.
PMID: 39600395
PMC: 11590746.
DOI: 10.5414/ALX02533E.
Libon F, Caron J, Nikkels A
Dermatol Ther (Heidelb). 2024; 14(7):1729-1738.
PMID: 38874894
PMC: 11264653.
DOI: 10.1007/s13555-024-01193-1.
Yamamura Y, Nakashima C, Otsuka A
Front Med (Lausanne). 2024; 11:1342176.
PMID: 38590314
PMC: 10999685.
DOI: 10.3389/fmed.2024.1342176.
Holdrowicz A, Wozniacka A
J Clin Med. 2024; 13(6).
PMID: 38541978
PMC: 10971646.
DOI: 10.3390/jcm13061754.
Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives.
Pareek A, Kumari L, Pareek A, Chaudhary S, Ratan Y, Janmeda P
Cells. 2024; 13(5.
PMID: 38474389
PMC: 10931328.
DOI: 10.3390/cells13050425.
proteases trigger eosinophil-mediated skin inflammation.
Kline S, Orlando N, Lee A, Wu M, Zhang J, Youn C
Proc Natl Acad Sci U S A. 2024; 121(6):e2309243121.
PMID: 38289950
PMC: 10861893.
DOI: 10.1073/pnas.2309243121.
Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis.
Haertle J, Kienlin P, Begemann G, Werfel T, Roesner L
Sci Rep. 2023; 13(1):16628.
PMID: 37789035
PMC: 10547677.
DOI: 10.1038/s41598-023-42595-z.
Clinical trials of antibody drugs in the treatments of atopic dermatitis.
Zhou G, Huang Y, Chu M
Front Med (Lausanne). 2023; 10:1229539.
PMID: 37727760
PMC: 10506412.
DOI: 10.3389/fmed.2023.1229539.
Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents.
Caffarelli C, Giannetti A, Gianni G, Ricci G
Front Med (Lausanne). 2023; 10:1214963.
PMID: 37654660
PMC: 10466416.
DOI: 10.3389/fmed.2023.1214963.
Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis.
Kim J, Lee J, Huh Y, Kim K, Chaparala V, Krueger J
J Invest Dermatol. 2023; 144(1):43-52.e6.
PMID: 37419444
PMC: 11060321.
DOI: 10.1016/j.jid.2023.06.194.
Atopic Dermatitis Across Shades of Skin.
Quan V, Erickson T, Daftary K, Chovatiya R
Am J Clin Dermatol. 2023; 24(5):731-751.
PMID: 37336869
DOI: 10.1007/s40257-023-00797-1.
Exosomes with overexpressed miR 147a suppress angiogenesis and infammatory injury in an experimental model of atopic dermatitis.
Shi C, Pei S, Ding Y, Tao C, Zhu Y, Peng Y
Sci Rep. 2023; 13(1):8904.
PMID: 37264030
PMC: 10235063.
DOI: 10.1038/s41598-023-34418-y.
Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model.
Hua C, Liang Q, Chen S, Zhu J, Tang Y, Chen X
Stem Cell Res Ther. 2023; 14(1):147.
PMID: 37248497
PMC: 10227992.
DOI: 10.1186/s13287-023-03365-w.
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis.
Tsuji G, Yamamura K, Kawamura K, Kido-Nakahara M, Ito T, Nakahara T
Biomedicines. 2023; 11(5).
PMID: 37238974
PMC: 10215969.
DOI: 10.3390/biomedicines11051303.
Overview of Atopic Dermatitis in Different Ethnic Groups.
Chiricozzi A, Maurelli M, Calabrese L, Peris K, Girolomoni G
J Clin Med. 2023; 12(7).
PMID: 37048783
PMC: 10095524.
DOI: 10.3390/jcm12072701.
Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
Peng F, Zong J, Zhao T, Shi P, Lu M, Qu X
Front Pharmacol. 2023; 14:1119103.
PMID: 37033625
PMC: 10073476.
DOI: 10.3389/fphar.2023.1119103.
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.
Facheris P, Jeffery J, Del Duca E, Guttman-Yassky E
Cell Mol Immunol. 2023; 20(5):448-474.
PMID: 36928371
PMC: 10203371.
DOI: 10.1038/s41423-023-00992-4.
The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis.
Yamanaka K, Kono Y, Iida S, Nakanishi T, Nishimura M, Matsushima Y
Int J Mol Sci. 2023; 24(4).
PMID: 36834723
PMC: 9960233.
DOI: 10.3390/ijms24043310.
The role of heterodimer IL-17-A/F in atopic dermatitis.
Krzysiek J, Lesiak A, Szybka M, Michalak A, Pastuszak-Lewandoska D, Grzegorczyk J
Postepy Dermatol Alergol. 2023; 39(6):1093-1100.
PMID: 36686022
PMC: 9837588.
DOI: 10.5114/ada.2022.122604.
